To evaluate the potential association between reduced immune cell infiltration and the prognosis of NSCLC patients, we analyzed the progression-free survival data for the TCGA NSCLC samples, stratifying them based on MUC21 expression. Here, MUC21 is linked to non-small cell lung carcinoma.